- Home
- ERAS vs SLQT Comparison
ERAS vs SLQT Comparison
Compare ERAS & SLQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- SLQT
- Stock Information
- Founded
- ERAS 2018
- SLQT 1999
- Country
- ERAS United States
- SLQT United States
- Employees
- ERAS N/A
- SLQT N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- SLQT Specialty Insurers
- Sector
- ERAS Health Care
- SLQT Finance
- Exchange
- ERAS Nasdaq
- SLQT Nasdaq
- Market Cap
- ERAS 723.8M
- SLQT 682.6M
- IPO Year
- ERAS 2021
- SLQT 2020
- Fundamental
- Price
- ERAS $1.90
- SLQT $4.44
- Analyst Decision
- ERAS Strong Buy
- SLQT Hold
- Analyst Count
- ERAS 5
- SLQT 1
- Target Price
- ERAS $5.70
- SLQT $4.00
- AVG Volume (30 Days)
- ERAS 1.5M
- SLQT 1.3M
- Earning Date
- ERAS 11-12-2024
- SLQT 02-05-2025
- Dividend Yield
- ERAS N/A
- SLQT N/A
- EPS Growth
- ERAS N/A
- SLQT N/A
- EPS
- ERAS N/A
- SLQT N/A
- Revenue
- ERAS N/A
- SLQT $1,381,309,000.00
- Revenue This Year
- ERAS N/A
- SLQT $12.73
- Revenue Next Year
- ERAS N/A
- SLQT $14.03
- P/E Ratio
- ERAS N/A
- SLQT N/A
- Revenue Growth
- ERAS N/A
- SLQT 28.72
- 52 Week Low
- ERAS $1.64
- SLQT $1.07
- 52 Week High
- ERAS $3.45
- SLQT $4.62
- Technical
- Relative Strength Index (RSI)
- ERAS 29.70
- SLQT 70.88
- Support Level
- ERAS $1.77
- SLQT $3.58
- Resistance Level
- ERAS $2.84
- SLQT $4.39
- Average True Range (ATR)
- ERAS 0.18
- SLQT 0.33
- MACD
- ERAS -0.07
- SLQT 0.01
- Stochastic Oscillator
- ERAS 12.15
- SLQT 83.77
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.